Emergent BioSolutions
EBS
#6744
Rank
C$0.89 B
Marketcap
C$16.81
Share price
3.88%
Change (1 day)
26.69%
Change (1 year)

Emergent BioSolutions (EBS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$1.22 Billion

According to Emergent BioSolutions 's latest financial reports the company's total liabilities are C$1.22 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Emergent BioSolutions - Total liabilities on balance sheet (from 2004 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$1.30 B-16.42%
2023-12-31C$1.55 B-35.49%
2022-12-31C$2.41 B40.67%
2021-12-31C$1.71 B-6.31%
2020-12-31C$1.83 B13.18%
2019-12-31C$1.61 B-2.52%
2018-12-31C$1.65 B736.11%
2017-12-31C$0.19 B-60.49%
2016-12-31C$0.50 B-4.04%
2015-12-31C$0.52 B17.05%
2014-12-31C$0.44 B205.71%
2013-12-31C$0.14 B20.52%
2012-12-31C$0.12 B-8.28%
2011-12-31C$0.13 B4.47%
2010-12-31C$0.12 B19.38%
2009-12-31C$0.10 B-4.53%
2008-12-31C$0.11 B8.89%
2007-12-31C$0.10 B-12.11%
2006-12-31C$0.11 B145.81%
2005-12-31C$47.26 M-14.66%
2004-12-31C$55.37 M
2002-12-31C$29.43 M-67.99%
2001-12-31C$91.94 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Merck
MRK
C$108.32 B 8,737.68%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
C$39.23 M-96.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$85.50 B 6,876.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
C$69.86 M-94.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$161.33 B 13,062.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$45.48 B 3,611.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
C$5.15 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA